Modern Liver MR Imaging Contrast Agents

Abstract

MR Imaging has revealed high performance for focal liver lesion detection and characterization during a single examination procedure. Liver-specific contrast media have shown to further increase the detection rate. The first liver-specific contrast media approved where not injected as a bolus avoiding the acquisition of early dynamic sequences. The recently approved gadolinium-based agent gadoxetic acid is offering for the first time a combination of an excellent and extracellular space contrast medium-equivalent safety profile, a high diagnostic accuracy in lesion detection and characterisation by a highly liver-specific uptake.